Showing results (171-180 of 745) with videos related to
Sort By:
Pageof 75
Clinical Pharmacology and Therapeutics|August 9, 2005
Intracellular and plasma pharmacokinetics of nevirapine in human immunodeficiency virus-infected individualsLisa M Almond, Damitha Edirisinghe, Mark Dalton, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavirSusan Clarke, Fiona Mulcahy, Colm Bergin, et al.Contraception|September 1, 1987
The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule formD J Back, S R Killick, P J Stevenson, et al.Arzneimittel-Forschung|September 1, 1992
Pharmacokinetics and serum protein binding of 3-keto-desogestrel in women during three cycles of treatment with a low-dose combination oral contraceptiveW Kuhnz, G al-Yacoub, J Power, et al.Contraception|January 1, 1986
The bioavailability of ethinyloestradiol and levonorgestrel in patients with an ileostomyS F Grimmer, D J Back, M L Orme, et al.The Journal of Antimicrobial Chemotherapy|June 25, 2013
Interactions between tenofovir and nevirapine in CD4+ T cells and monocyte-derived macrophages restrict their intracellular accumulationN J Liptrott, P Curley, D Moss, et al.Contraception|April 1, 1991
The lack of interaction between temafloxacin and combined oral contraceptive steroidsD J Back, J Tjia, C Martin, et al.European Journal of Clinical Pharmacology|January 1, 1993
Effect of chlormethiazole on hepatic monooxygenases activity in vivoH Mönig, D J Back, H T Heidemann, et al.Contraception|July 1, 1983
The effect of cotrimoxazole on oral contraceptive steroids in womenS F Grimmer, W L Allen, D J Back, et al.Pediatric Radiology|August 6, 2017
Classification of pediatric urinary tract dilation: the new languageJeanne S Chow, Jeffrey L Koning, Susan J Back, et al.Pageof 75